Re: Farmas USA
El autor va largo
http://seekingalpha.com/article/2793275-epizyme-the-ugly-duckling-of-the-2014-biotech-rally?ifp=0
Poca cosa, aunque compras recientes son
http://openinsider.com/search?q=epzm
EPZM
CÓDIGO AMIGO
El autor va largo
http://seekingalpha.com/article/2793275-epizyme-the-ugly-duckling-of-the-2014-biotech-rally?ifp=0
Poca cosa, aunque compras recientes son
http://openinsider.com/search?q=epzm
EPZM
si hubiera +20% gap de por medio yo me quedo quieto que ya me da vertigo .
Pero suerte Sietesoles con ese cambio de tendencia, ojala!!
gas
edito: acabo de releerte, no dices nada de gap en UGAZ, joer que tarde es mejor lo dejo para mañana que la noche ya me confunde :)Post usano que comenta sobre la entrevista reciente de NVAX con los de Bioinvest ( no tenemos acceso porque es de pago y un paston ).
En relacion a las 52 ofertas de empleo que tiene la empresa en su web.
In the interview with Bioinvest, NVAX indicated that most of the new employees they have added and are adding are for manufacturing of the VLP. NVAX has 2 commercial scale facilities (I don't know the specifics, this is what Erck said). As you know, they have constantly talked about initiating GMP for whatever initiative they have (latest Ebola, and GMP is Good Manufacturing Practices, basically a protocol that is set up to conform and pass FDA standards), and currently are legging up RSV and flu. Apparently this takes a lot of employees -- I think it was clear from a lot of these and earlier positions that many are manufacturing related.
Oh, the company did mention that if they need additional manufacturing capacity in the near term (might have been Ebola related question, I do not recall) that they have a contract with someone for any additional capacity. I have no idea who this might be. "
NVAX
sobre el tema de Kowa y las ventas de Vascepa
AMRN
Viva el DOLAR 1,1915 !!